Iterum Therapeutics Ltd.

/Iterum Therapeutics Ltd.

Overnight

Iterum Therapeutics Ltd.

Pharmaceutical

Overnight Offering: We are a clinical-stage pharmaceutical company dedicated to developing and commercializing sulopenem to be potentially the first and only oral and intravenous (IV) branded penem available globally.

Symbol

ITRM

Last Closing Price
$1.49

Shares
8,695,653

Anticipated Date
February 4, 2021

Underwriters
H.C. WAINWRIGHT & CO., INC.

This offering is no longer available

To view the prospectus for Iterum Therapeutics Ltd., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277